| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/2009 | US20090239829 Thioaryl substituted inhibitors of zinc proteases and their use |
| 09/24/2009 | US20090239828 Adhesive preparation |
| 09/24/2009 | US20090239827 Compounds having lipid lowering properties |
| 09/24/2009 | US20090239826 Compositions and methods for the regulation of homocysteine levels within the body |
| 09/24/2009 | US20090239825 Multi-carotenoids compositions and uses therefor |
| 09/24/2009 | US20090239824 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/24/2009 | US20090239823 Foods and drinks having health benefits and method for adding health benefits to foods and drinks |
| 09/24/2009 | US20090239822 Process for the preparation of esters of diacerein with hyaluronic acid and pharmaceutical compositions containing such esters |
| 09/24/2009 | US20090239821 Destruction of microbial products by enzymatic digestion |
| 09/24/2009 | US20090239820 Compounds and methods for treatment of solid tumors |
| 09/24/2009 | US20090239819 Peritoneal dialysis solution test method |
| 09/24/2009 | US20090239818 Effective treatment of ovarian cancer using triciribine and related compounds |
| 09/24/2009 | US20090239817 Organic thiophosphate antiretroviral agents |
| 09/24/2009 | US20090239816 Multitargeting Interfering RNAs And Methods Of Their Use And Design |
| 09/24/2009 | US20090239815 Novel human microRNAs associated with cancer |
| 09/24/2009 | US20090239814 Carbohydrate Conjugates as Delivery Agents for Oligonucleotides |
| 09/24/2009 | US20090239813 Analogs of Alpha Galactosyceramide and Uses thereof |
| 09/24/2009 | US20090239812 Use of c7 sugars in prevention and treatment of mycoses |
| 09/24/2009 | US20090239811 Polycationic compounds and uses thereof |
| 09/24/2009 | US20090239810 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239804 Prevention and treatment of osteoarthritis |
| 09/24/2009 | US20090239803 Bite-size carbohydrate nutritional products and methods for using same |
| 09/24/2009 | US20090239793 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 09/24/2009 | US20090239791 Pharmaceutical composition containing lipophilic substance which inhibits il-2 production |
| 09/24/2009 | US20090239783 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 09/24/2009 | US20090239301 Use of vinca alkaloids and salts thereof |
| 09/24/2009 | US20090239236 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/24/2009 | US20090238907 Topical Compositions Containing Bacillus Coagulans Extracellular Products and Uses Thereof |
| 09/24/2009 | US20090238903 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 09/24/2009 | US20090238901 Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome |
| 09/24/2009 | US20090238896 Compositions and methods for diagnosing and treating melanoma |
| 09/24/2009 | US20090238884 Compositions for site-specific delivery of imatinib and methods of use |
| 09/24/2009 | US20090238880 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 09/24/2009 | US20090238879 Delivery scaffolds and related methods of use |
| 09/24/2009 | US20090238878 Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances With Reduced Ostwald Ripening |
| 09/24/2009 | US20090238877 Agent For Improving Fine Wrinkles |
| 09/24/2009 | US20090238876 Bisphosphonates for treating endometriosis |
| 09/24/2009 | US20090238874 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |
| 09/24/2009 | US20090238873 Extended release formulation containing a wax |
| 09/24/2009 | US20090238871 Pharmaceutical composition |
| 09/24/2009 | US20090238870 Dividable galenical form allowing modified release of the active ingredient |
| 09/24/2009 | US20090238869 Propranolol formulations |
| 09/24/2009 | US20090238868 Abuse-resistant oral dosage forms and method of use thereof |
| 09/24/2009 | US20090238866 Chewable capsules |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238862 Methods and Compositions for Seprase Inactivation |
| 09/24/2009 | US20090238861 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 09/24/2009 | US20090238860 Adhesive Patch Less Irritative to Skin |
| 09/24/2009 | US20090238859 Sinus delivery of sustained release therapeutics |
| 09/24/2009 | US20090238858 Compositions and Methods for Treating Ophthalmic Diseases |
| 09/24/2009 | US20090238852 Methods for controlling intracellular calcium levels associated with an ischemic event |
| 09/24/2009 | US20090238846 S/O type external preparation |
| 09/24/2009 | US20090238845 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238839 Somatic Transgene Immunization and Related Methods |
| 09/24/2009 | US20090238836 Hip kinase for fertility control |
| 09/24/2009 | US20090238828 Combinations for the Treatment of Diseases involving Cell Proliferation |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |
| 09/24/2009 | US20090238818 Induction of Antigen Specific Immunnologic Tolerance |
| 09/24/2009 | US20090238810 Ophthalmic composition |
| 09/24/2009 | US20090238809 Application Methods to Rapidly Alter Disease and Injury States Using Molecular Transport of B6 |
| 09/24/2009 | US20090238805 Methods and compositions for increasing rna interference |
| 09/24/2009 | US20090238797 Nicotine-carrier vaccine formulation |
| 09/24/2009 | US20090238795 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/24/2009 | US20090238793 Toll like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration |
| 09/24/2009 | US20090238790 Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 09/24/2009 | US20090238785 Novel Aldehydic Musks and Derivatives Thereof |
| 09/24/2009 | US20090238783 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 09/24/2009 | US20090238782 Cosmetic composition which includes at least one polysaccharide derived from bacteria of hydrothermal origin |
| 09/24/2009 | US20090238780 Amla extract for transdermal application |
| 09/24/2009 | US20090238773 Use of Morpholino Compounds for the Treatment of Halitosis |
| 09/24/2009 | US20090238772 Methods and compositions for prevention or treatment of rsv infection |
| 09/24/2009 | US20090238771 Pharmaceutical formulations |
| 09/24/2009 | US20090238770 Organic compounds |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | US20090238761 Novel Aryl Piperazine Derivatives With Medical Utility |
| 09/24/2009 | US20090238760 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/24/2009 | US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 09/24/2009 | US20090238756 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 09/24/2009 | US20090238754 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | US20090236239 Soft contact lens package product and method of packaging soft contact lens |
| 09/24/2009 | DE102008015428A1 Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid Cooling compositions for the human skin and / or mucous membrane contact with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridin-2-yl) ethyl-cyclohexanecarboxamide and / or ( 1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid |
| 09/24/2009 | DE102008015426A1 Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen Cooling cosmetic or dermatological preparations with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridyne-2-yl) ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid to reduction of skin reddening |
| 09/24/2009 | DE102008015424A1 Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol Cooling cosmetic or dermatological preparations with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridyne-2-yl) ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid with menthoxypropanediol |
| 09/24/2009 | DE102008015366A1 Lyophilisierte Nanoemulsion Lyophilized nanoemulsion |
| 09/24/2009 | DE102008015250A1 Neue Medikamenten Synthese New drug synthesis |
| 09/24/2009 | DE102008015101A1 Kauzusammensetzung und deren Verwendung Kauzusammensetzung and their use |
| 09/24/2009 | DE102008014855A1 Use of formulations for treating pathological vascular calcification occurring in renal disease, where the formulation contains trimagnesium dicitrate and/or trimagnesium diisocitrate as hydrate/anhydrate form |
| 09/24/2009 | DE102008013623A1 Pharmazeutische Zusammensetzung zur Diagnose oder Behandlung von Zinkfinger Protein assoziierten Erkrankungen A pharmaceutical composition for diagnosis or treatment of diseases associated zinc finger protein |
| 09/24/2009 | CA2756115A1 Antiseptic compositions for the treatment of infections |
| 09/24/2009 | CA2755933A1 Modulation of the immune response |
| 09/24/2009 | CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 09/24/2009 | CA2728756A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2719008A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | CA2718993A1 Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | CA2718969A1 Adaptive biochemical signatures |
| 09/24/2009 | CA2718966A1 Anti-inflammatory drug delivery system |
| 09/24/2009 | CA2718959A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |